BeiGene Stock (NASDAQ:BGNE), Quotes and News Summary

Q: What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.

Open	$166.300
Close	$161.130
Volume / Avg.	196.397K / 213.809K
Day Range	161.000 - 166.300
52 Wk Range	126.968 - 247.495
Market Cap	$18.277B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	-
Days to Cover	13.24

Recent News

Tracking Last Week's Top Performers: Are These 15 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)

Last week's top performers included Vertiv Holdings, Tesla, Tyler Technologies, and Newmont Corporation.

Lekha Gupta

Hillhouse Boosts Longi Position After Robe, As It Pivots To Global Focus

Key Takeaways: Hillhouse Capital has raised its shareholding in Longi back to 5% after being investigated by the Chinese securities regulator for violating disclosure rules

The Bamboo Works

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeiGene (BGNE) stock?

You can purchase shares of BeiGene (NASDAQ: BGNE) through any online brokerage.

View our list of the best stock brokerages.

Who are BeiGene's (BGNE) competitors?

Other companies in BeiGene’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for BeiGene (BGNE) stock?

The latest price target for BeiGene (NASDAQ: BGNE) was reported by TD Cowen on Thursday, May 9, 2024. The analyst firm set a price target for 254.00 expecting BGNE to rise to within 12 months (a possible 57.64% upside). 17 analyst firms have reported ratings in the last year.

Current Stock Price for BeiGene (BGNE)?

The stock price for BeiGene (NASDAQ: BGNE) is $161.13 last updated May 10, 2024 at 4:00 PM EDT.

Does BeiGene (BGNE) pay a dividend?

There are no upcoming dividends for BeiGene.

When is BeiGene (NASDAQ:BGNE) reporting earnings?

BeiGene’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is BeiGene (BGNE) going to split?

There is no upcoming split for BeiGene.

What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-